Combination of NMDA-enhancing and Anti-inflammatory Treatments for Ultra-resistant Schizophrenia

Abroad (travel likely)RecruitingPHASE2

Conditions

Schizophrenia

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Department of Psychiatry, China Medical University Hospital, Taichung, Taiwan
Contact: Study coordinator (Hsien-Yuan Lane, M.D., Ph.D) · hylane@gmail.com · 886 4 22052121

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Genetic Basis of the Risk and Consequences of Cannabis Exposure in Humans

Schizophrenia · Cannabis Use Disorder

Abroad (travel likely)RecruitingPHASE1

West Haven, United States

Efficacy of NBI-1117568 in Preventing Relapse in Adults With Schizophrenia

Schizophrenia

Abroad (travel likely)RecruitingPHASE3

Garden Grove, United States · La Habra, United States

Metformin Alleviates Abnormal Glucose Metabolism Induced by Statins in Schizophrenia Patients

Schizophrenia

Abroad (travel likely)RecruitingPHASE3

Zhumadian, China · Changsha, China

Investigating the Effect of Diroximel Fumarate on Glutathione in Schizophrenia

Schizophrenia Disorders

Abroad (travel likely)Recruiting

London, United Kingdom · London, United Kingdom